Seeking Domestic Pharmaceuticals
ID: 36C77025Q0199Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/fdbc0204eff141b6b22676a47bdac040/view
Timeline
  1. 1
    Posted Mar 28, 2025, 12:00 AM UTC
  2. 2
    Updated Mar 28, 2025, 12:00 AM UTC
  3. 3
    Due Apr 3, 2025, 9:30 PM UTC
Description

The Department of Veterans Affairs is seeking qualified domestic manufacturers to provide seven specific pharmaceuticals for its Consolidated Mail Outpatient Pharmacy (CMOP) program. The procurement aims to identify sources capable of supplying medications such as Trazodone, Sertraline, and Hydroxychloroquine, which are essential for the healthcare needs of veterans across multiple facilities in the United States. Interested companies are encouraged to submit capability statements detailing their products, distribution capabilities, and compliance with federal regulations, as responses will inform future contracting strategies. For further inquiries, interested parties may contact Josie M Linaweaver at josie.linaweaver@va.gov or by phone at 913-684-0155.

Point(s) of Contact
Josie M Linaweaver
(913) 684-0155
josie.linaweaver@va.gov
Files
Title
Posted
RFI DRAFT - March 2025.docx
Mar 28, 2025, 2:04 PM UTC
The Department of Veterans Affairs is conducting market research for the Consolidated Mail Outpatient Pharmacy (CMOP) program to identify sources capable of providing domestically manufactured pharmaceuticals. This Sources Sought announcement is not a solicitation but aims to engage qualified contractors in early discussions about potential requirements. The CMOP seeks manufacturers for several specified medications, including Trazodone, Sertraline, and Hydroxychloroquine, which will be needed for seven facilities across the country. Interested companies are encouraged to submit a capability statement along with details regarding their products, distribution, and supply chain reliability. They must also comply with federal regulations and be registered in the System for Award Management. The NAICS code for this request is 325412, indicating the industry standard related to pharmaceutical manufacturing. While responses to this announcement will be considered non-binding, they provide valuable insights into market capabilities and help shape future contracting strategies.
Lifecycle
Title
Type
Seeking Domestic Pharmaceuticals
Currently viewing
Sources Sought
Similar Opportunities
6505--Perphenazine Tablets (VA-25-00037353)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to ensure a reliable supply of this pharmaceutical product for both the Department of Veterans Affairs and the Department of Defense, with a focus on service-disabled veteran-owned, women-owned, and HUBZone small businesses. The procurement process will adhere to the Drug Supply Chain Security Act and require compliance with FDA regulations, including Good Manufacturing Practices. Interested offerors must submit their proposals by May 1, 2025, at 2:30 PM CDT, and can direct inquiries to Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov.
6505--Topiramate Tablets (VA-25-00047941)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the supply of Topiramate Tablets, a pharmaceutical product essential for meeting the medication needs of VA facilities and other government agencies. The procurement aims to establish a contract through the VA Pharmaceutical Prime Vendor Program, requiring offerors to submit detailed proposals that include pricing for a base year and four option years, with a 0.5% Cost Recovery Fee incorporated. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to specific packaging requirements, and maintenance of current Good Manufacturing Practices (cGMP) verified by the FDA are critical components of the contract. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details regarding the solicitation.
NALTREXONE -50MG -100CT - Multiple CMOPs - 770-25-3-801-0426
Buyer not available
The Department of Veterans Affairs is preparing to solicit proposals for the procurement of 50mg Naltrexone tablets, packaged in 100-count bottles, for delivery to multiple Consolidated Mail Outpatient Pharmacies (CMOP) across the United States. This presolicitation notice (RFQ: 36C77025Q0114) indicates a commitment to full and open competition, allowing all responsible vendors to submit quotations by the response deadline of May 6, 2025, at 4 PM Central Time. The procurement of these pharmaceuticals is crucial for meeting the ongoing healthcare needs of veterans, ensuring compliance with regulatory standards such as the Drug Supply Chain Security Act. Interested vendors must direct their responses to Contract Specialist Jennifer Knight via email at jennifer.knight@va.gov, with the estimated issue date for the solicitation set for April 29, 2025.
6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
6505--Metformin IR Tablets
Buyer not available
The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Metformin HCL IR Tablets as part of its pharmaceutical prime vendor programs, which also serve the Department of Defense (DoD). Offerors are required to submit pricing for various bottle sizes and quantities, ensure compliance with FDA regulations, and adhere to the Drug Supply Chain Security Act (DSCSA), including providing a unique National Drug Code (NDC) for each product. This procurement is crucial for maintaining a reliable source of pharmaceutical products, ensuring consistent availability and pricing while meeting federal regulatory standards. Interested parties should contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov for further details, and proposals must be submitted in accordance with the outlined requirements within the specified timeframe.
6505--Buspirone RFP
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Buspirone HCL, a pharmaceutical product essential for the healthcare services provided to veterans. The procurement process requires vendors to submit pricing for multiple line items covering a base year and four option years, ensuring compliance with the Drug Supply Chain Security Act and FDA Good Manufacturing Practices. This contract aims to maintain a reliable supply chain for federal healthcare providers, including the VA, Department of Defense, and Indian Health Service, while securing volume-based pricing for the necessary pharmaceuticals. Interested vendors must submit their offers by May 8, 2025, at 2:30 PM CT, and can direct inquiries to Contract Specialist Amber Zavala at amber.zavala@va.gov.
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract aims to ensure an uninterrupted supply of this essential medication for a period of one year, with options for four additional one-year terms, emphasizing the VA's commitment to maintaining critical pharmaceutical supplies. The estimated annual requirement is approximately 91,583 bottles, and interested offerors must ensure their product has a unique National Drug Code (NDC) and complies with specific packaging requirements, including safety caps. The solicitation is expected to be issued electronically on or around April 26, 2025, with a response deadline of May 13, 2025; inquiries can be directed to Deb Fassl at Deborah.Fassl@va.gov.
6505--Ranolazine Sustained Action (SA) Tablets
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Ranolazine Sustained Action Tablets, a pharmaceutical product essential for veteran healthcare. Bidders are required to submit pricing for a base year and four option years, along with compliance documentation including National Drug Code (NDC) numbers and adherence to packaging specifications as mandated by the Drug Supply Chain Security Act. This procurement underscores the government's commitment to ensuring a reliable supply of quality medications while adhering to federal standards, including Good Manufacturing Practices (cGMP). Interested parties should contact Contract Specialist Deborah S. Fassl at Deborah.Fassl@va.gov for further details regarding submission requirements and deadlines.
6505--Loperamide Capsules (VA-25-00032225)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the supply of Loperamide Hydrochloride (HCL) 2mg capsules, as outlined in solicitation number 36E79725R0025. Offerors must provide pricing for a base year and four additional one-year options, including a 0.5% Cost Recovery Fee and unique 11-digit National Drug Codes (NDC) for their products, while adhering to regulatory standards such as the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This procurement is crucial for ensuring the availability of essential pharmaceutical products to VA facilities and other government health service providers. The deadline for proposal submissions has been extended to April 30, 2025, at 2:30 PM Central Time, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further information.
760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.